Diagnostic Tests for Adrenocortical Carcinoma
Links shared publicly online about this topic
General Information About Adrenocortical Carcinoma
cancer.gov — “Expert-reviewed information summary about the treatment of adrenocortical carcinoma.” View full resource at cancer.gov
Most Recently Shared on August 4, 2009 at 1:58 am By:
Oncology Medical Article | The diagnostic value of the thinprep pap test in endometrial carcinoma
mdlinx.com — “Oncology Medical Article: The diagnostic value of the thinprep pap test in endometrial carcinoma” View full resource at mdlinx.com
Most Recently Shared on March 13, 2012 at 9:53 am By:
The diagnostic value of the thinprep pap test in endometrial carcinoma: Diagnostic Cytopathology http://t.co/iYiowiZj #oncology
Combination HPV Diagnostic Test For Head And Neck Cancer Outperformed Other Tests
medicalnewstoday.com — “Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinoma, a form of head and” View full resource at medicalnewstoday.com
Most Recently Shared on October 4, 2011 at 7:05 am By:
Combination HPV Diagnostic Test For Head And Neck Cancer Outperformed Other Tests: Researchers have determined t... http://t.co/et2e4pA2
Combo HPV Diagnostic Test for Head and Neck Cancer Outperforms Other Tests | Oral Cancer News
oralcancernews.org — “Combo HPV Diagnostic Test for Head and Neck Cancer Outperforms Other Tests | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on October 6, 2011 at 2:23 pm By:
OCF News Update: Combo HPV Diagnostic Test for Head and Neck Cancer Outperforms Other Tests http://t.co/DS5u2cTI
Wako Diagnostics Announces 510(k) Clearance for Microfluidic Test System | IVD Technology
ivdtechnology.com — “Wako Diagnostics has received 510(k) clearance from FDA to market the TASWako i30 instrument with alphafetoprotein L3 (AFP-L3) and des-gamma-carboxy prothrombin (DCP) IVD tests in the United States. The AFP-L3 and DCP assays are intended for use by healthcare professionals as an aid in the risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma (HCC).” View full resource at ivdtechnology.com
Most Recently Shared on March 1, 2011 at 6:01 pm By:
Wako Diagnostics Announces510(k) Clearance for Microfluidic Test System http://tinyurl.com/4qyld9a
Digital Pathology Blog: CBLPath Receives Approval From New York State Department of Health for XALKORI(R) Companion Diagnostic
tissuepathology.com — “CBLPath recently announced it is one of a select few labs within the United States to offer Vysis(R) ALK Break Apart fluorescence in situ hybridization (FISH) testing for non-small cell lung carcinoma (NSCLC). The Vysis ALK FISH test detects rearrangements...” View full resource at tissuepathology.com
Most Recently Shared on March 26, 2012 at 8:34 pm By:
CBLPath Receives Approval From New York State Department of Health for XALKORI(R) Companion Diagnostic http://t.co/TQfb0wWk
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Skin Cancer OW
Organizing skin cancer resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

